Quantcast

Latest Biomarker Stories

2014-05-06 08:34:50

Enables physicians to pursue more effective treatment plans for patients who are chemoradiation resistant CHICAGO, May 6, 2014 /PRNewswire/ -- Castle Biosciences Inc. announced that data from two clinical validation studies of its DecisionDx-EC multi-biomarker test were reviewed in an oral presentation at the Digestive Disease Week (DDW) Annual Meeting. The data show that the test accurately predicts response to pre-surgical chemoradiation therapy (CTRT) in patients with esophageal...

2014-05-05 23:07:52

Join us for this month’s calendar of webinars hosted by Xtalks, featuring insightful discussions about clinical data, biomarkers, drug discovery & development, oncology and pharmacovigilance in human and animal trials. Toronto, Canada (PRWEB) May 05, 2014 Learn about current industry hot topics through online sessions which will be presented by leading industry experts in clinical trial, pharmaceutical, and biotech industries et al. Participate in the discussion and stay updated and...

2014-05-05 20:25:53

LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Molecular Diagnostics in Cancer Testinghttp://www.reportbuyer.com/pharma_healthcare/diagnostics/molecular_diagnostics_cancer_testing.htmlMolecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umbrella of molecular diagnostics include first-generation amplification, DNA...

2014-05-01 04:22:38

PARIS, May 1, 2014 /PRNewswire/ -- ENTEROME Bioscience SA, a pioneer in the development of innovative disease management solutions based on a deep understanding of the gut microbiome, is pleased to announce that it has raised EUR10 million in the first tranche of a Series B fund raising. The funding has been led by the Company's existing investors, Seventure (including from its new Health for Life Capital fund, which is dedicated to companies focused on health, nutrition and...

2014-04-30 12:30:34

Data Highlight Physician and Payer Expectations for New Symptomatic and Disease-Modifying Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass., April 30, 2014 /PRNewswire/ -- Decision Resources Group finds that surveyed U.S. neurologists are particularly receptive to novel symptomatic agents and would prescribe Lundbeck/Otsuka's selective 5-HT6 receptor antagonist Lu-AE58054 to a median 25 percent of their drug-treated mild to moderate Alzheimer's disease patients,...

2014-04-28 23:05:53

A new blood test that has the potential to diagnose Alzheimer’s disease in an individual and significantly advances drug testing and research on the disease, has been developed through grant funding by the Cure Alzheimer's Fund. Boston, MA (PRWEB) April 28, 2014 A new blood test that has the potential to diagnose Alzheimer’s disease in an individual and significantly advances drug testing and research on the disease, has been developed through grant funding by the Cure...

Two Breath Compounds May Be Associated With Larynx Cancer
2014-04-28 04:00:54

FECYT - Spanish Foundation for Science and Technology Researchers at the Rey Juan Carlos University and the Alcorcón Hospital (Madrid) have compared the volatile substances exhaled by eleven people with cancer of larynx, with those of another twenty healthy people. The results show that the concentrations of certain molecules, mainly ethanol and 2-butanone, are higher in individuals with carcinoma, therefore they act as potential markers of the disease. Human breath contains thousands...

2014-04-25 23:05:55

This research report categorizes the proteomics market inton instrumentation technologies, reagents, services types, and geography. http://www.marketsandmarkets.com/Market-Reports/proteomics-market-731.html (PRWEB) April 25, 2014 The “Proteomics Market by Technology (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents & Services - Global Forecast to 2018", analyzes...

2014-04-23 23:04:09

New research report “Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)” worked out by Kelly Scientific Publications is now available at MarketPublishers.com. London, UK (PRWEB) April 23, 2014 To date, more than 32 million people worldwide are living with cancer. The most frequently occurred types of cancer include breast,...

2014-04-22 08:34:43

NORTH KINGSTOWN, R.I., April 22, 2014 /PRNewswire/ -- Kenneth Blum, PhD, President and CEO of IGENE, LLC, has long been associated with leading drug monitoring laboratory Dominion Diagnostics in a scientific research and advisory role. Blum, who sits on Dominion's Addiction and Scientific Advisory Board, was recently appointed Chief Scientific Advisor to Dominion Diagnostics. At the 2014 American Society of Addiction Medicine (ASAM) Annual Medical-Scientific Conference in Orlando,...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.